Goldman vs. Morgan Stanley: Which Stock Has Stronger Upside?

Goldman Sachs and Morgan Stanley are positioned to benefit from a rebound in M&A and capital markets: Goldman reported $6.8 billion in investment banking fees (up 19% YoY) in the first nine months of 2025 while Morgan Stanley’s Institutional Securities IB fees rose 14% YoY. Both cleared the Fed’s 2025 stress test and announced shareholder returns — MS hiked its quarterly dividend 8% to $1.00 (yield 2.42%) and GS raised its dividend 33% to $4 (yield 1.99%) — while liquidity appears ample (MS long-term debt $324.1bn with $368.1bn average liquidity; GS cash $169bn and $350bn unsecured debt). Valuation and estimate dynamics are mixed: GS trades cheaper on trailing P/E (14.78x vs MS 16.11x) and P/TBV metrics, but earnings estimate revisions and recent share-price momentum favor MS (Zacks Rank #1 vs GS #3), leading the author to view MS as offering stronger near-term upside.

Analysis

Market structure: Winners are Morgan Stanley (MS) and wealth/asset managers as deal activity rebounds and investors rotate to recurring-fee businesses; Goldman Sachs (GS) wins if M&A becomes a blockbuster but is more exposed to capital-markets cyclicality. The GS retreat from consumer banking tightens its focus on IB/trading, concentrating underwriting supply into fewer dominant players which should lift fee pricing if deal volume increases >15% Y/Y over next 12 months. Cross-asset: tighter bank credit spreads, modest USD strength into US financials, and higher equity vols on trading-sensitive names (GS) versus lower vols for fee-based franchises (MS).

Risk assessment: Key tail risks are a sudden M&A freeze (reversal >20% in announced deal value within 3 months), regulatory/litigation shocks to buybacks, or a liquidity event compressing bank funding spreads by >50bp. Immediate (days) moves will track Fed commentary and stress-test headlines; short-term (weeks–months) hinges on Q4/Q1 IB fee prints; long-term (quarters–years) depends on MS’s wealth AUM growth and GS’s ability to offset consumer exit with trading/IB gains. Hidden dependency: MS’s private-markets push (EquityZen) links it to late-cycle valuation resets.

Trade implications: Tactical bias favoring MS over GS — MS offers defensive earnings growth (consensus +22.7% for 2025) and higher dividend yield (2.42%). Direct plays: core long MS equity, hedge market beta or short GS to isolate IB risk. Options: buy 6–9 month MS call spreads 15–30% OTM to capture upside with limited cash; consider buying protective puts on GS if holding long exposure.

Contrarian angles: Consensus may underprice upside in GS — P/E 14.8x and P/TBV below industry median imply optionality if M&A surges; a 20%+ jump in announced global deal value could re-rate GS quickly. Conversely, MS integration risk for acquired platforms and private-markets valuation markdowns are underappreciated; if MS AUM flows reverse by >5% QoQ, downside will be meaningful. Watch buyback cadence vs. capital buffers as an unintended fragility.

Key Decisions for Investors

• Establish a 2–3% long position in Morgan Stanley (MS) within 2 weeks; target 12–18% upside over 6–12 months (driven by fee growth and dividend), place a stop-loss at 10% and trim to 1% if MS reports AUM outflows >3% QoQ or IB fees miss consensus by >8% on next print.
• Initiate a pair trade: long MS 2.5% / short GS 1.5% to express preference for fee-stability vs. IB cyclicality; rebalance if the relative spread (MS/GS performance) diverges by >20% or if GS IB fees exceed $9B TTM (trigger to reduce short exposure).
• Buy a 6–9 month MS call spread (buy 15% OTM, sell 30% OTM) sized to 0.5–1% notional of portfolio to capture upside with defined risk; cost should be <0.5% portfolio and held into Q1 2026 earnings unless IV doubles.
• Avoid increasing exposure to trading-heavy regional or consumer banks (including long GS exposure >1.5% of portfolio) until two consecutive quarters of rising IB fees (>5% QoQ) are confirmed; consider protective put on any existing GS position (3–6 month, 10% OTM) if buybacks accelerate without clear capital buffer improvement.